News

Elara Capital observes that Aurobindo Pharma has 14 biosimilars in the pipeline. The company has also filed 3 biosimilars for ...
ICICI Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in its ...
Nifty Pharma dropped 0.66% at intraday as it underperformed benchmark Nifty 50 which dropped 0.46% at intraday.
Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.
Indian drugmakers are responding with geographic diversification, supply-chain resilience and acquisition of US assets to ...
ABB India Ltd., Aurobindo Pharma Ltd., Paras Defence and Space Technologies Ltd. and Quess Corp are some of the other ...
Here is the complete list of stocks that will remain in focus today as they trade ex-dividend on August 8, along with their ...
In a market overshadowed by US tariff threats and a tumbling rupee, cautious trading is essential. This article outlines the ...
Several companies like Ceat and Indian Oil will trade ex-dividend from August 8, 2025. These companies recently announced ...
Sandeep Tandon of Quant Mutual Fund believes India is decoupling from developed economies, particularly within the ...
Shriram Life Insurance is strategically expanding its focus on annuity and pension products, anticipating a significant ...